ATP7A and neoplasm: Based on the above results, we found that the MC1 subtype with the optimal prognosis had higher IFNγ score and T cell lytic activity, lower angiogenesis score and TIDE score, indicating that this subtype had stronger immunogenicity and better tumor microenvironment, and was more likely to benefit from immunotherapy.